GENAZZANI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 24.993
AS - Asia 12.305
EU - Europa 10.149
SA - Sud America 1.591
AF - Africa 311
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 5
Totale 49.398
Nazione #
US - Stati Uniti d'America 24.619
SG - Singapore 3.897
GB - Regno Unito 3.568
CN - Cina 3.374
IT - Italia 2.047
HK - Hong Kong 1.450
BR - Brasile 1.242
VN - Vietnam 1.182
SE - Svezia 860
DE - Germania 800
UA - Ucraina 609
FI - Finlandia 580
TR - Turchia 484
BD - Bangladesh 438
RU - Federazione Russa 412
FR - Francia 365
KR - Corea 342
IN - India 252
BG - Bulgaria 230
CA - Canada 167
ID - Indonesia 124
MX - Messico 124
AR - Argentina 119
IQ - Iraq 112
ES - Italia 110
NL - Olanda 105
PK - Pakistan 102
PL - Polonia 89
JP - Giappone 82
ZA - Sudafrica 80
IE - Irlanda 76
AE - Emirati Arabi Uniti 54
EG - Egitto 54
EC - Ecuador 50
IR - Iran 47
MA - Marocco 46
PH - Filippine 46
AU - Australia 40
LT - Lituania 40
VE - Venezuela 38
CL - Cile 37
MY - Malesia 34
CO - Colombia 33
RO - Romania 31
SA - Arabia Saudita 30
BE - Belgio 29
TH - Thailandia 29
KE - Kenya 28
UZ - Uzbekistan 28
PE - Perù 27
CH - Svizzera 25
DZ - Algeria 25
TN - Tunisia 23
AT - Austria 22
IL - Israele 21
AZ - Azerbaigian 20
JO - Giordania 20
UY - Uruguay 20
CZ - Repubblica Ceca 19
PT - Portogallo 18
GR - Grecia 16
PY - Paraguay 16
KG - Kirghizistan 15
NP - Nepal 15
DK - Danimarca 14
ET - Etiopia 13
HU - Ungheria 13
KZ - Kazakistan 13
PA - Panama 13
AL - Albania 11
CR - Costa Rica 11
TW - Taiwan 11
BH - Bahrain 10
OM - Oman 10
BO - Bolivia 9
HN - Honduras 9
SN - Senegal 9
TT - Trinidad e Tobago 9
GH - Ghana 8
LB - Libano 8
NG - Nigeria 8
PS - Palestinian Territory 8
EE - Estonia 7
JM - Giamaica 7
NO - Norvegia 7
PR - Porto Rico 7
RS - Serbia 7
SY - Repubblica araba siriana 7
BY - Bielorussia 5
DO - Repubblica Dominicana 5
GE - Georgia 5
GT - Guatemala 5
KH - Cambogia 5
MD - Moldavia 5
NI - Nicaragua 5
SI - Slovenia 5
YE - Yemen 5
KW - Kuwait 4
LK - Sri Lanka 4
MK - Macedonia 4
Totale 49.323
Città #
Southend 2.535
Fairfield 2.494
Ashburn 2.391
Singapore 2.288
Santa Clara 2.215
Woodbridge 1.618
Hong Kong 1.427
Houston 1.280
Jacksonville 1.189
Hefei 1.132
Chandler 1.040
Seattle 920
Wilmington 847
Ann Arbor 772
Cambridge 751
San Jose 737
Dearborn 679
Beijing 633
London 599
Nyköping 534
Los Angeles 452
Council Bluffs 441
Chicago 415
Ho Chi Minh City 383
The Dalles 371
Helsinki 345
Modena 342
Seoul 325
Hanoi 285
Princeton 242
San Diego 238
Buffalo 232
Sofia 223
Milan 214
Eugene 193
Lauterbourg 189
Izmir 168
Salt Lake City 160
New York 158
Munich 117
Shanghai 113
Moscow 111
São Paulo 108
Dallas 105
Des Moines 94
Rome 85
Columbus 82
Guangzhou 77
Frankfurt am Main 75
Bologna 74
Dublin 73
Elk Grove Village 73
Orem 73
Boardman 68
Bremen 67
Tampa 67
Redwood City 66
Jakarta 59
Tokyo 58
Haiphong 53
Kent 50
Da Nang 46
Mexico City 44
Norwalk 44
Phoenix 44
Warsaw 44
Miano 42
Rio de Janeiro 41
Turku 41
Baghdad 40
Istanbul 40
Naples 39
Falls Church 37
Montreal 36
Lancaster 35
Chennai 33
Miami 33
Philadelphia 33
Detroit 32
Sterling 32
Parma 31
Johannesburg 30
Cagliari 29
Belo Horizonte 28
Florence 28
Mumbai 28
San Francisco 28
Amsterdam 27
Brooklyn 27
Dhaka 27
Redondo Beach 27
Atlanta 25
Brasília 25
Cairo 25
Kunming 25
Turin 25
Dongguan 24
Nairobi 24
Tashkent 24
Toronto 24
Totale 34.472
Nome #
Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea 666
Inositol as putative integrative treatment for PCOS 597
Effects of a Combination of Alpha Lipoic Acid and Myo-Inositol on Insulin Dynamics in Overweight/Obese Patients with PCOS. 508
Hypothalamic amenorrhea: from diagnosis to therapeutical approach. 416
Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback 401
Acetyl-L-Carnitine (ALC) administration positively affects reproductive axis in hypogonadotropic women with functional hypothalamic amenorrhea 378
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 378
Validation of italian version of the Women's Health Questionnaire: Assessment of quality of life of women from the general population and those attending menopause centers 376
Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia 342
Might DHEA be Considered a Beneficial Replacement Therapy in the Elderly ? 338
One-year therapy with 10 mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu 327
Diagnostic and therapeutic approach to hypothalamic amenorrhea 324
Estriol administration modulates luteinizing hormone secretion in women with functional hypothalamic amenorrhea 322
Neuroendocrine correlates of premenstrual syndrome: changes in the pulsatile pattern of plasma LH. 321
Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients 319
Neuroendocrine changes in luteal function in patients with premenstrual syndrome. 316
Effect of a 2-month treatment with Klamin®, a Klamath algae extract, on the general well-being, antioxidant profile and oxidative status of postmenopausal women 315
Use of metformin in the treatment of polycystic ovary syndrome 314
Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients 311
Life events impact in patients with secondary amenorrhoea. 309
Inositol and human reproduction. From cellular metabolism to clinical use 305
Spontaneous endogenous pulsatile release of kisspeptin is temporally coupled with luteinizing hormone in healthy women 305
Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients 305
Allopregnanolone concentration in hippocampus of prepubertal rats and female rats throughout estrous cycle 301
Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause 297
Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome 296
Allopregnanolone concentrations and premenstrual syndrome 295
Acute infusion of naloxone, an opioid receptor antagonist, does not modify serum leptin concentrations in amenorrheic and healthy women 292
Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications 292
A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program. 290
Stressful life events and affective disorders inhibit pulsatile LH secretion in hypothalamic amenorrhea. 287
Advances in neurosteroids: Role in clinical practice 284
Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome 284
Color Doppler analysis in oligo and amenorrheic women with polycystic ovary syndrome 282
Estimation of instantaneous secretory rates and intrinsic characteristics of luteinizing hormone secretion in women with Kallmann syndrome before and after estriol administration. 278
Actin Cytoskeleton Remodelling by Sex Steroids in Neurones 276
Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance 276
The relevance of inositols treatment for PCOS before and during ART 275
A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome. 274
Effetto degli estratti di alga Klamath sul benessere e sui fenomeni di stress ossidativo nelle pazienti in menopausa 273
Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets 269
Short-term estriol administration modulates hypothalamo-pituitary function in patients with functional hypothalamic amenorrhea (FHA) 269
Obesità e benessere: i rischi per la salute della donna obesa 266
Androgens Regulate T47D Cells Motility and Invasion through Actin Cytoskeleton Remodeling 264
Modulatory effects of l-carnitine plus l-acetyl-carnitine on neuroendocrine control of hypothalamic functions in functional hypothalamic amenorrhea (FHA) 264
Dall'uso del solo DHEA alla sua associazione con la terapia ormonale sostitutiva 263
La Sindrome Premestruale: clinica, fisiopatologia e indicazioni terapeutiche 258
Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS 256
Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution 253
Episodic secretion of activin A in pregnant women 251
Adrenal function under long-term raloxifene administration 250
Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers 244
Changes in Dopaminergic control of circulating melanocyte- stimulating hormone-related peptides at puberty. 244
Functional Hypothalamic Amenorrhea as Stress Induced Defensive System 243
EFFECT OF CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN ON PROSTAGLANDIN RELEASE FROM CULTURED MATERNAL DECIDUA AND ON CONTRACTILE ACTIVITY OF HUMAN MYOMETRIUM IN-VITRO 242
Color Doppler analysis in lean and obese women with polycystic ovary syndrome. 240
Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1) 239
DHEA as a putative replacement therapy in the elderly 237
Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both 236
Assessment of the QoL in Italian menopausal women: Comparison between HRT users and non-users 234
Effects of cyproheptadine clorhydrate, a serotonin receptor antagonist, on endocrine parameters in weight-loss related amenorrhea 234
FSH SECRETORY PATTERN AND DEGREE OF CONCORDANCE WITH LH IN AMENORRHEIC, FERTILE, AND POSTMENOPAUSAL WOMEN. 234
Corticotropin-releasing factor-binding protein: Origins and possible functions 233
PULSATILE SECRETION OF GONADOTROPINS AND PROLACTIN DURING THE FOLLICULAR AND LUTEAL PHASES OF THE MENSTRUAL-CYCLE - ANALYSIS OF INSTANTANEOUS SECRETION RATE AND SECRETORY CONCOMITANCE 232
Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women. 232
Long-term GnRH-agonist administration revealed a GnRH-independent mechanism stimulating FSH discharge in humans 230
Effects of estetrol on migration and invasion inT47-D breast cancer cells through the actin cytoskeleton 230
Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia 229
Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome 228
Effects of Klamath Algae extract on psychological disorders and depression in menopausal women: a pilot study 228
Color Doppler hysterosalpingography in the diagnosis of tubal patency. 228
Effects of red clover extracts on breast cancer cell migration and invasion 228
Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders 227
Female precocious puberty, obesity and polycystic-like ovaries 227
Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea 227
Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery 225
Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women 224
Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea. 223
Dydrogesterone exerts endothelial anti-inflammatory actions decreasing expression of leukocyte adhesion molecules 223
Bollettino di Endocrinologia Ginecologica 222
Which form of HRT should we choose? 221
Ultrasonographic and color Doppler analysis in the treatment of polycystic ovary syndrome 221
Neuromodulatory role of opioidergic system on hypothalamus-pituitary-gonadal axis during puberty 220
The role of color doppler imaging in the diagnosis of polycystic ovary syndrome 220
Effect of short term sibutramine on gonadotropin spontaneous pulsatile release in normogonadotropinemic amenorrheic subjects 220
Progestinici e fibromatosi uterina 218
Efficacy on menopausal neurovegetative symptoms and some plasma lipids blood levels of an herbal product containing isoflavones and other plant extracts 218
Endocrine and clinical effects of myo-inositol administration in policystyc ovary syndrome. A randomized study. 218
The duration of prolactin secretory bursts from the pituitary is independent from both prolactin and gonadal steroid plasma levels in women and in men 218
Acetyl-L-Carnitine effect on pituitary and plasma *-endorphin responsiveness to different chronic intermittent stressors. 218
Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea 217
. Opioid control of gonadotrophin secretion in humans. 217
Surgical technique of endometrioma excision impacts on the ovarian reserve. Single-port access laparoscopy versus multiport access laparoscopy: a case control study 216
Aspetti endocrini, diagnostici e terapeutici delle menimetrorragie in età perimenopausale. 215
Estrogen replacement therapy modulates spontaneous GH secretion but does not affect GH-RH-induced GH response and low T3 syndrome in women with hypothalamic amenorrhea associated to weight-loss 214
Endocrinologia Ginecologica 213
FREQUENCY OF PROLACTIN PULSATILE RELEASE IN NORMAL MEN AND IN AGONADAL PATIENTS IS NEITHER COUPLED TO LH-RELEASE NOR INFLUENCED BY ANDROGEN MODULATION 213
Modulatory effects of a synthetic steroid (tibolone) and estradiol on spontaneous and GH-RH-induced GH secretion in postmenopausal women 211
Progestins modulate the action of estrogen on gonadotropin-releasing hormone, luteinizing hormone and prolactin in the rat. 211
Melatonin treatment delays reproductive aging of female rat via the opiatergic system. 209
Totale 27.259
Categoria #
all - tutte 201.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 201.207


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021243 0 0 0 0 0 0 0 0 0 0 0 243
2021/20223.487 66 595 353 284 66 116 279 200 355 217 546 410
2022/20233.192 360 282 178 272 396 518 57 285 429 45 154 216
2023/20242.352 93 145 144 152 558 205 248 326 36 74 147 224
2024/20258.093 334 106 80 620 1.540 1.033 358 490 1.091 744 782 915
2025/202616.876 1.059 725 1.632 1.677 2.214 1.332 1.951 908 1.715 1.613 1.130 920
Totale 49.740